Milner Therapeutics Symposium
The Milner Therapeutics Symposium is a one day event that will bring together world-leading scientists in cancer biology, neurobiology, immunology and regenerative medicine with top companies from the pharmaceutical and biotechnology sector. Attendance is free but registration is essential as places are limited.
The registration deadline is 21 October 2016.
To register your interest for the Symposium please click here. As there are limited places you will be informed whether you have a place when registration has closed. Please note that only companies affiliated with the Milner Therapeutics Institute are eligible to attend. For more information on how to become affiliated email email@example.com.
Allan Bradley - Kymab and Sanger Institute
Susan Galbraith - AstraZeneca
Peter McNaughton - Kings College, London
Rab Prinjha - GlaxoSmithKline
David Rees - Astex
David Rubinsztein - University of Cambridge
Tsuneaki Sakata - Shionogi
Bill Sellers - Novartis
Molly Stevens - Imperial College, London
Charles Swanton - Francis Crick Institute
Mark Vidal - Harvard Medical School